Join to View Full Profile
101 Manning DrRoom N4051 Campus Box 7596Chapel Hill, NC 27599
Dr. Jackson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Wesley Jackson is a neonatologist based in Chapel Hill, NC, serving as an Associate Professor at UNC since 2022, having been an Assistant Professor there since 2018. He completed his residency in Pediatrics at the University of Alabama at Birmingham Medical Center and his fellowship in Neonatal-Perinatal Medicine at the University of North Carolina at Chapel Hill. Dr. Jackson graduated from the University of Texas Southwestern Medical School in 2012. His research focuses on pharmacokinetics and pharmacotherapy in infants, especially those with hypoxic-ischemic encephalopathy and pulmonary hypertension. Dr. Jackson leads clinical trials on caffeine use for hypoxic-ischemic encephalopathy.
Education & Training
University of North Carolina HospitalsFellowship, Neonatal-Perinatal Medicine, 2015 - 2018
University of Alabama Medical CenterResidency, Pediatrics, 2012 - 2015
University of Texas Southwestern Medical SchoolClass of 2012
Certifications & Licensure
NC State Medical License 2015 - 2025
AL State Medical License 2014 - 2015
American Board of Pediatrics Pediatrics- American Board of Pediatrics Neonatal-Perinatal Medicine
Clinical Trials
- Caffeine for Hypoxic-Ischemic Encephalopathy Start of enrollment: 2019 Aug 14
Roles: Contact, Principal Investigator
- Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) Start of enrollment: 2020 Mar 05
Roles: Contact
- Dose Optimization of Caffeine for HIE Start of enrollment: 2024 Jul 26
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 1 citationsPopulation Pharmacokinetics of Caffeine in Infants with Hypoxic-Ischemic Encephalopathy: A Phase I, Dose-Escalating Trial.Elizabeth J Thompson, Daniel Gonzalez, Julie Dumond, Christoph P Hornik, Alison Kilborn
Journal of Clinical Pharmacology. 2025-02-12 - 1 citationsCorrelating Severity of Pulmonary Hypertension by Echocardiogram with Mortality in Premature Infants with Bronchopulmonary Dysplasia.Rachel D Torok, Robert A Gardner, Piers C A Barker, Andrew W McCrary, Jennifer S Li
American Journal of Perinatology. 2024-12-01 - Methylxanthine use in infants with hypoxic-ischemic encephalopathy: a retrospective cohort study.Madeleine E Laughon, Jacob K Johnson, Rachel G Greenberg, Reese H Clark, Wesley M Jackson
Scientific Reports. 2024-08-17
Grant Support
- Dose Optimization for Novel Drugs for Infants with Hypoxic-Ischemic EncephalopathyUNIV OF NORTH CAROLINA CHAPEL HILL2023–2028
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
